Uttar Pradesh bans Coldrif cough syrup after 14 children die in Madhya Pradesh, sparking protests and calls for accountability.
The Uttar Pradesh government on Sunday (October 5, 2025) banned the Coldrif cough syrup manufactured by Shreesan Pharmaceutical following reports of severe side effects, resulting in the death of 14 children in Madhya Pradesh.
The State’s Assistant Commissioner of Drug Administration has issued instructions to all drug inspectors to collect samples of the cough syrup manufactured by Shreesan Pharmaceutical Chhindwara from both government and private institutions across Uttar Pradesh.
Tragic deaths of children in Chhindwara due to Coldrif syrup prompt Madhya Pradesh to ban its sale statewide.
FDA issues urgent advisory to suspend Coldrif Syrup sales due to DEG contamination, linked to child fatalities in multiple states.
BCDA halts sale of Coldrif cough syrup in West Bengal due to child deaths, warns against stocking.
A medical representative from Sresan Pharma was arrested in MP over contaminated cough syrup linked to 24 children's deaths.
NEW DELHI: At least three Indian states have banned a cough syrup after several children died allegedly after consuming the…
Three states ban the cough syrup after children die allegedly after consuming the product.
